The main goal of our retrospective–prospective study is to analyze the immunohistochemical expression of PD-L1 alongside CD8-positive tumor-infiltrating lymphocytes in newly diagnosed patients with cervical invasive squamous cell carcinoma without prior neoadjuvant therapy and to establish their prognostic role. This evidence concerns the gene CD8A and neoplasm.